Sanofi
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
(0.0% 1d) (-2.5% 1m) (-18.1% 1y) (0.0% 2d) (1.7% 3d) (3.4% 7d) (NaN% volume)
Earnings Calendar:
Market Cap: $ 120,636,938,849
http://www.sanofi.com
Sec Filling | Patents | 100409 employees
Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes and cardiovascular, established prescription products and generics, and research, development, and production activities. The Consumer Healthcare segment includes the commercial operations for its Consumer Healthcare products. The Vaccines segment consists commercial operations of Sanofi Pasteur. The company was founded in 1973 and is headquartered in Paris, France.
vaccine cardiovascular diabetes diabetic
add to watch list Paper trade email alert is off
Press-releases
Biopharma Layoff Tracker 2024: Tessera, BenevolentAI, Pfizer and More Cut Staff
Published: 2024-04-24 (Crawled : 05:00) - biospace.com/
OCX | News | $2.5 -0.4% -0.4% 23K
|
Health Technology
| Email alert
Add to watchlist
GOOG | News 4 | $159.82 1.18% 1.17% 16M
|
Technology Services
| Email alert
Add to watchlist
GOOGL | News S | $158.17 1.21% 1.19% 21M
|
Technology Services
| Email alert
Add to watchlist
AMRN | News | $0.8827 1.96% 1.93% 760K
|
Health Technology
| Email alert
Add to watchlist
GLPG | News | $29.47 1.38% 1.36% 120K
|
Health Technology
| Email alert
Add to watchlist
MOR | News | $18.04 0.45% 0.44% 180K
|
Health Technology
| Email alert
Add to watchlist
NKTR | News | $1.415 4.04% 3.89% 1.1M
|
Health Technology
| Email alert
Add to watchlist
PTCT | News S | $25.38 -2.27% -2.32% 750K
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
| Email alert
Add to watchlist
TXMD | News | $1.875 -0.27% -0.27% 21K
|
Health Technology
| Email alert
Add to watchlist
VXRT | News | $0.7422 -2.66% -2.74% 1.5M
|
Health Technology
| Email alert
Add to watchlist
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
| Email alert
Add to watchlist
RLYB | News | $1.84 3.96% 3.8% 240K
|
| Email alert
Add to watchlist
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
| Email alert
Add to watchlist
GLPGF | News | $35.5157 71.75% 4.8K
|
Health Technology
| Email alert
Add to watchlist
MPSYF | News | $70.28 -71.33% 110
|
Health Technology
| Email alert
Add to watchlist
biopharma
Press Release: Rilzabrutinib LUNA 3 phase 3 study met primary endpoint in immune thrombocytopenia
Published: 2024-04-23 (Crawled : 05:00) - globenewswire.com
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 1.7%
H: 0.0%
C: 0.0%
study
Sanofi’s $3.7B Principia Buy Starts to Pay Off with Phase III Rilzabrutinib Win
Published: 2024-04-23 (Crawled : 13:30) - biospace.com/
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 1.7%
H: 0.0%
C: 0.0%
FDA Rejects Abeona’s Gene Therapy, Approves ImmunityBio’s Bladder Cancer Treatment
Published: 2024-04-23 (Crawled : 13:30) - biospace.com/
PRGO | $30.49 1.43% 0.0% 1.1M
|
Health Technology
|
| O: 0.13%
H: 1.89%
C: 1.3%
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: 0.89%
H: 0.0%
C: 0.0%
ABT | News | $107.59 0.49% -0.09% 3.8M
|
Health Technology
|
| O: 0.56%
H: 0.41%
C: -0.07%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 1.7%
H: 0.0%
C: 0.0%
fda bladder cancer treatment
Response Pharmaceuticals’ Drug Candidate for the Treatment of Antipsychotic-Induced Weight Gain (AIWG) Achieves Primary Endpoint in Phase 1b Clinical Trial
Published: 2024-04-23 (Crawled : 14:30) - biospace.com/
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 1.7%
H: 0.0%
C: 0.0%
drug candidate treatment for trial response
Biopharma Layoff Tracker 2024: BenevolentAI, Pfizer, Sanofi and More Cut Staff
Published: 2024-04-23 (Crawled : 14:30) - biospace.com/
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: 0.89%
H: 0.0%
C: 0.0%
VXRT | News | $0.7422 -2.66% -2.74% 1.5M
|
Health Technology
|
| O: 1.97%
H: 0.0%
C: 0.0%
TXMD | News | $1.875 -0.27% -0.27% 21K
|
Health Technology
|
| O: -0.53%
H: 1.07%
C: 0.53%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 1.7%
H: 0.0%
C: 0.0%
PTCT | News S | $25.38 -2.27% -2.32% 750K
|
Health Technology
|
| O: 0.02%
H: 0.0%
C: 0.0%
NKTR | News | $1.415 4.04% 3.89% 1.1M
|
Health Technology
|
| O: 1.84%
H: 0.0%
C: 0.0%
MOR | News | $18.04 0.45% 0.44% 180K
|
Health Technology
|
| O: 0.39%
H: 0.0%
C: 0.0%
GLPG | News | $29.47 1.38% 1.36% 120K
|
Health Technology
|
| O: 0.38%
H: 0.0%
C: 0.0%
AMRN | News | $0.8827 1.96% 1.93% 760K
|
Health Technology
|
| O: 0.57%
H: 0.0%
C: 0.0%
GOOGL | News S | $158.17 1.21% 1.19% 21M
|
Technology Services
|
| O: 0.48%
H: 0.0%
C: 0.0%
GOOG | News 4 | $159.82 1.18% 1.17% 16M
|
Technology Services
|
| O: 0.41%
H: 0.0%
C: 0.0%
OCX | News | $2.5 -0.4% -0.4% 23K
|
Health Technology
|
| O: -1.99%
H: 0.0%
C: 0.0%
RLYB | News | $1.84 3.96% 3.8% 240K
|
|
| O: 1.98%
H: 0.0%
C: 0.0%
biopharma sanofi
Curio Digital Therapeutics Inc. Announces the U.S. Food and Drug Administration (FDA) Clearance of MamaLift Plus™, the First Prescription Digital Therapeutic Authorized for the Treatment of Postpartum Depression (PPD)
Published: 2024-04-23 (Crawled : 00:00) - biospace.com/
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 1.7%
H: 0.0%
C: 0.0%
first drug authorized food depression treatment clearance for therapeutics
Regeneron to Highlight Advances in Genetic Medicine Research at American Society of Gene and Cell Therapy (ASGCT)
Published: 2024-04-22 (Crawled : 22:00) - globenewswire.com
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 1.7%
H: 0.0%
C: 0.0%
REGN | News | $906.84 0.74% 0.74% 340K
|
Health Technology
|
| O: 0.51%
H: 0.78%
C: 0.18%
genetic cell research therapy
Over-The-Counter Drug Market size is set to grow by USD 58.54 billion from 2023-2027, Abbott Laboratories, Achelios Therapeutics Inc. and AstraZeneca Plc, and more to emerge as Some of the Key Vendors, Technavio
Published: 2024-04-22 (Crawled : 22:00) - prnewswire.com
RBGPF | News | $52.06 6.46% 4.8K
|
Consumer Non-Durables
|
| O: 0.98%
H: 5.46%
C: -0.89%
GLAXF | News | $20.305 -14.18% 630
|
Health Technology
|
| O: -3.15%
H: 0.0%
C: -0.61%
AZNCF | News | $138.73 -4.19% 3.7K
|
Health Technology
|
| O: 0.96%
H: 2.38%
C: 0.17%
NVSEF | News | $95.11 6.88% 490
|
Health Technology
|
| O: 1.69%
H: 0.02%
C: -0.74%
RBGLY | News | $10.59 -2.05% 850K
|
Manufacturing
|
| O: -0.28%
H: 2.18%
C: 1.99%
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: 4.32%
H: 0.0%
C: 0.0%
GSK | News | $41.24 1.6% 0.0% 2.3M
|
Health Technology
|
| O: 0.17%
H: 1.48%
C: 1.43%
ABT | News | $107.59 0.49% -0.09% 3.8M
|
Health Technology
|
| O: 0.56%
H: 0.41%
C: -0.07%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 1.7%
H: 0.0%
C: 0.0%
AZN | News | $70.85 1.03% 1.02% 5.6M
|
Health Technology
|
| O: 0.43%
H: 0.95%
C: 0.6%
drug astrazeneca set key therapeutics market
23andMe, Innate Pharma Tap Antibodies to Target NK Cells for Cancer
Published: 2024-04-22 (Crawled : 05:00) - biospace.com/
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 0.85%
H: 0.0%
C: 0.0%
pharma cancer for
Last 15 days Sec forms
| File Id | Form | Published Date | Transaction Date | Direction | Code | Amount Transacted | Owned Amount |
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Last 48 Hours Insiders Buying
MEGI | $11.975 1.87% 0.04% 140K
|
|
00:30
CTRN P 29000 | $22.25 0.14% 0.13% 100K
|
Retail Trade
|
22:00
CONN | $3.71 1.37% 1.35% 72K
|
Retail Trade
|
21:30
TGEN P 6000 | $0.6897 39.71% 2.3K
|
Utilities
|
18:30
CMTV P 700 | $15.74 17.43% 12K
|
Finance and Insurance
|
18:30
FNB | $13.63 2.17% 0.0% 2.5M
|
Finance
|
17:30
RMCF | $3.57 0.28% 2.8K
|
Consumer Non-Durables
|
20:10